James M. Markert
Impact in
Papers in
- Co-authors
- G. Yancey GillespieAmy MalickDonald M. CoenRobert L. MartuzaRichard J. WhitleyKatherine RuffnerCheryl A. PalmerJacqueline N. Parker
- Journals
- Neuro-Oncology (10 papers)Neurosurgery (10 papers)Journal of Neuro-Oncology (8 papers)International Journal of Radiation Oncology*Biology*Physics (8 papers)Journal of Clinical Oncology (8 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
James M. Markert
190 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Genetics 4.4k
- Genetics 1.6k
- Oncology 3.5k
- Epidemiology 2.3k
- Biotechnology 575
Countries citing papers authored by James M. Markert
This map shows the geographic impact of James M. Markert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Markert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Markert more than expected).
Fields of papers citing papers by James M. Markert
This network shows the impact of papers produced by James M. Markert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Markert. The network helps show where James M. Markert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James M. Markert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 28 | |
| 11 | 2019 | 26 | |
| 12 | 2017 | 45 | |
| 13 | 2017 | 3 | |
| 14 | 2016 | 35 | |
| 15 | 2016 | 122 | |
| 16 | 2014 | 3 | |
| 17 | 2014 | 60 | |
| 18 | 2010 | 152 | |
| 19 | 2004 | 55 | |
| 20 | Experimental therapy of human glioma by means of a genetically engineered virus mutant | 1991 | 2 |
About James M. Markert
James M. Markert is a scholar working on Genetics, Genetics, Oncology, Epidemiology and Neurology, having authored 199 papers that have together received 8.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (88 papers), Herpesvirus Infections and Treatments (58 papers), Glioma Diagnosis and Treatment (52 papers), CAR-T cell therapy research (52 papers), Brain Metastases and Treatment (27 papers), Cytomegalovirus and herpesvirus research (19 papers), Immunotherapy and Immune Responses (17 papers) and RNA Interference and Gene Delivery (16 papers). The work is most often cited by research in Genetics (4.4k citations), Genetics (1.6k citations), Oncology (3.5k citations), Epidemiology (2.3k citations) and Biotechnology (575 citations). James M. Markert has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include G. Yancey Gillespie, Amy Malick, Donald M. Coen, Robert L. Martuza, Richard J. Whitley, Katherine Ruffner, Cheryl A. Palmer, Jacqueline N. Parker, John B. Fiveash and Gregory K. Friedman. Their work appears in journals such as Neuro-Oncology, Neurosurgery, Journal of Neuro-Oncology, International Journal of Radiation Oncology*Biology*Physics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.